Kellner Capital’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History
Bought
Maintained
Sold
Kellner Capital's DICE Position: Q3 2023 in Review
Kellner Capital sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 29,200 shares — an estimated $1.36M sold.
Kellner Capital first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $1.36M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.
- Kellner Capital reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Kellner Capital sold 29,200 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $1.36M.
- Kellner Capital first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
- Kellner Capital's DICE Therapeutics, Inc. Common Stock position peaked at $1.36M in Q2 2023.
- 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.
Based on Kellner Capital's 13F filing for Q3 2023, filed 13 Nov 2023.